Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3,289,474
-
Total 13F shares
-
103,397
-
Share change
-
+103,397
-
Total reported value
-
$734,048
-
Price per share
-
$7.11
-
Number of holders
-
19
-
Value change
-
+$734,048
-
Number of buys
-
19
Institutional Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q2 2025
As of 30 Jun 2025,
Cellectar Biosciences, Inc. - Common Shares (CLRB) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,397 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, HRT FINANCIAL LP, Riverview Capital Advisers, LLC, BlackRock, Inc., UBS Group AG, MORGAN STANLEY, SIMPLEX TRADING, LLC, Tower Research Capital LLC (TRC), and RAYMOND JAMES FINANCIAL INC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.